Cited 0 times in
급성기 양극성우울증 약물치료 전략
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김세주 | - |
dc.date.accessioned | 2019-01-15T17:06:01Z | - |
dc.date.available | 2019-01-15T17:06:01Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 1015-4817 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/166804 | - |
dc.description.abstract | Of the different phases of bipolar disorder, bipolar depression is more prevailing and is more difficult to treat. However, there is a deficit in systemic research on the pharmacological treatment of acute bipolar depression. Therefore, consensuses on the pharmacological treatment strategies of acute bipolar depression has yet to be made. Currently, there are only three drugs approved by the Food and Drug Administration for acute bipolar depression : quetiapine, olanzapine-fluoxetine complex, and lurasidone. In clinical practice, other drugs such as mood stabilizers (lamotrigine, lithium, valproate) and/or the other atypical antipsychotics (aripiprazole, risperidone, ziprasidone) are frequently prescribed. There remains controversy on the use of antidepressants in bipolar depression. Here, we summarized the evidence of current pharmacological treatment options and reviewed treatment guidelines of acute bipolar depression from recently published studies. | - |
dc.description.statementOfResponsibility | open | - |
dc.format | application/pdf | - |
dc.language | Korean | - |
dc.publisher | 대한신경정신의학회 | - |
dc.relation.isPartOf | Journal of the Korean Neuropsychiatric Association (신경정신의학) | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | 급성기 양극성우울증 약물치료 전략 | - |
dc.title.alternative | Pharmacological Treatment Strategies for Acute Bipolar Depression | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Psychiatry (정신과학교실) | - |
dc.contributor.googleauthor | 김세주 | - |
dc.identifier.doi | 10.4306/jknpa.2018.57.4.287 | - |
dc.contributor.localId | A00604 | - |
dc.relation.journalcode | J01837 | - |
dc.subject.keyword | Acute bipolar depression | - |
dc.subject.keyword | Treatment guideline | - |
dc.subject.keyword | Atypical antipsychotics | - |
dc.subject.keyword | Mood stabilizers | - |
dc.subject.keyword | Antidepressants | - |
dc.contributor.alternativeName | Kim, Se Joo | - |
dc.contributor.affiliatedAuthor | 김세주 | - |
dc.citation.volume | 57 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 287 | - |
dc.citation.endPage | 300 | - |
dc.identifier.bibliographicCitation | Journal of the Korean Neuropsychiatric Association (신경정신의학), Vol.57(4) : 287-300, 2018 | - |
dc.identifier.rimsid | 58181 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.